Correlation Between Recursion Pharmaceuticals and 06406RAH0

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and 06406RAH0 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and 06406RAH0 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Recursion Pharmaceuticals and BANK NEW YORK, you can compare the effects of market volatilities on Recursion Pharmaceuticals and 06406RAH0 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of 06406RAH0. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and 06406RAH0.

Diversification Opportunities for Recursion Pharmaceuticals and 06406RAH0

0.01
  Correlation Coefficient

Significant diversification

The 3 months correlation between Recursion and 06406RAH0 is 0.01. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and BANK NEW YORK in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BANK NEW YORK and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with 06406RAH0. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BANK NEW YORK has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and 06406RAH0 go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and 06406RAH0

Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 13.42 times more return on investment than 06406RAH0. However, Recursion Pharmaceuticals is 13.42 times more volatile than BANK NEW YORK. It trades about 0.02 of its potential returns per unit of risk. BANK NEW YORK is currently generating about 0.03 per unit of risk. If you would invest  884.00  in Recursion Pharmaceuticals on September 12, 2024 and sell it today you would lose (138.00) from holding Recursion Pharmaceuticals or give up 15.61% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy99.09%
ValuesDaily Returns

Recursion Pharmaceuticals  vs.  BANK NEW YORK

 Performance 
       Timeline  
Recursion Pharmaceuticals 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
BANK NEW YORK 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BANK NEW YORK has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 06406RAH0 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Recursion Pharmaceuticals and 06406RAH0 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Recursion Pharmaceuticals and 06406RAH0

The main advantage of trading using opposite Recursion Pharmaceuticals and 06406RAH0 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, 06406RAH0 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 06406RAH0 will offset losses from the drop in 06406RAH0's long position.
The idea behind Recursion Pharmaceuticals and BANK NEW YORK pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Commodity Directory
Find actively traded commodities issued by global exchanges
Transaction History
View history of all your transactions and understand their impact on performance